Related Experiment Videos

Advances in the treatment of diabetic foot infections

David G Armstrong1, Benjamin A Lipsky

  • 1Podiatry Section, Department of Surgery, Southern Arizona Veterans Affairs Medical Center, and University of Arizona, Tucson, Arizona 85750, USA. armstrong@usa.net

Diabetes Technology & Therapeutics
|May 1, 2004
PubMed

Insights

Diabetic lower extremity infections, often caused by Staphylococcus aureus, lead to significant complications. Novel antibiotics and delivery systems offer new hope for managing these challenging infections.

Area of Science:

  • Infectious Diseases
  • Diabetology
  • Podiatry

Background:

  • Lower extremity infections are a major cause of morbidity and mortality in diabetic patients.
  • Staphylococcus aureus is a primary pathogen in diabetic foot infections, seen in both mild and severe cases.
  • Diabetic foot infections contribute significantly to healthcare costs.

Purpose of the Study:

  • To review the challenges and current management strategies for lower extremity infections in diabetic patients.
  • To highlight the role of pathogens, particularly Staphylococcus aureus, in diabetic foot infections.
  • To discuss the impact of peripheral vascular insufficiency and antibiotic resistance on treatment outcomes.

Main Methods:

  • Review of current literature on diabetic lower extremity infections.
  • Analysis of common pathogens and their prevalence.
  • Evaluation of diagnostic and therapeutic approaches, including surgical interventions and antibiotic therapy.
  • Discussion of emerging treatment modalities.

Main Results:

  • Gram-positive cocci, especially Staphylococcus aureus, are the leading cause of diabetic foot infections.
  • Infections can be monomicrobial or polymicrobial, varying with severity.
  • Osteomyelitis detection and appropriate culturing are crucial for treatment.
  • Peripheral vascular disease and antibiotic resistance are significant treatment barriers.

Conclusions:

  • Effective management requires clinical assessment, culturing, surgical intervention, and appropriate antibiotic therapy.
  • Novel antibiotics like levofloxacin and linezolid show promise.
  • Advanced delivery systems (e.g., antibiotic beads) may improve treatment efficacy.
  • Addressing vascular insufficiency and antibiotic resistance is key to overcoming treatment challenges.

Related Concept Videos

Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...